- Video: Sell Your Gold?
- Strategists: Embrace The Fear and Buy!
- Be Savvy: Play the Homebuilders
- Why Steel Stocks Will Beat Downturn
- Options Focus on Mines, Nokia and Chips
- Stock Picker: Check Out China
- 4-Star Mid-Cap Stocks
- Video: The Strong-Dollar Commodity Play
- Stock Picks: Jump On The Upturn
- Stock Picker: Familiar Names, New Opportunities
- Video: Sell Your Gold?
- S&P and Nasdaq on track for 5-day losing streak
- See What People Are Saying About... Merrill Downgrade
- A Tale of Two Homebuilders
- Google: Happy Tenth Anniversary--Now What?
- Strategists: Embrace The Fear and Buy!
- Patriots Quarterback Tom Brady On Pay And "Secrecy"
- NFL Commissioner Roger Goodell On League And NFL Network
- Chad Ocho Cinco Jerseys Will Be Available
- Nothing About New Cars Excites You? Are You Kidding?
- Surge in Joblessness May Deepen US Housing Slump
- Are We Headed for a Recession? Take Our Poll
- Treasurys Gain as Job Fears Shake Stock Market
- Rising Dollar to Curb Exports: Feldstein
- Nokia Shares Fall on Third-Quarter Warning
- Unemployment Hits 6.1%, Fueling Recession Fears
- Europe Slowdown Worse than US: Goldman
- How China's Bet on US Paper Went Wrong
- Altria in Talks to Buy UST for $10 Billion
At a time of market uncertainty, what can an investor count on? Knee replacements, for one thing. Bruce Nudell, UBS senior research analyst, takes that as his cue in picking some promising stocks.
"We really love the orthopedic market right now," he told CNBC. "It’s got about, in the United States, about five points of unit growth; hospitals are making a lot of money on these procedures…So this should be a high single-digit market for the long term."
Recommendations:
He's got a favorite among the orthopedics, too.
"We like Zimmer [ZMH
Loading...
()
] especially," he said. "We think it's an undervalued stock. We like Stryker [SYK
Loading...
()
] in the orthopedic space as well; Abbott (Laboratories) [ABT
Loading...
()
] we think is a terrific company, has terrific prospects right now."
And that's not all.
"Medtronic [MDT
Loading...
()
], I think, is going to have a really good year," he said, but added, "We question the longer-term topline there."
Disclosures:
Zimmer's firm makes a market in the securities of Zimmer, Stryker, and Abbott Laboratories, and has received compensation within the last 12 months from Medtronic, which is an investment banking client of the firm.
-- Brooke Sopelsa contributed to this article.
Del.icio.us
Digg It
Data is a real-time snapshot *Data is delayed at least 15 minutes